- Home
- RAMP vs INVA Comparison
RAMP vs INVA Comparison
Compare RAMP & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAMP | INVA |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RAMP | INVA |
|---|---|---|
| Price | $37.71 | $22.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $35.60 | $32.80 |
| AVG Volume (30 Days) | ★ 1.3M | 763.9K |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22500.00 | 816.67 |
| EPS | ★ 2.24 | 2.22 |
| Revenue | ★ $812,940,000.00 | $217,217,000.00 |
| Revenue This Year | $11.18 | $8.95 |
| Revenue Next Year | $9.09 | $12.65 |
| P/E Ratio | $16.84 | ★ $10.05 |
| Revenue Growth | 9.03 | ★ 62.63 |
| 52 Week Low | $21.71 | $16.52 |
| 52 Week High | $37.92 | $25.15 |
Technical Indicators
Market Signals| Indicator | RAMP | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 68.61 | 46.08 |
| Support Level | $37.25 | $22.21 |
| Resistance Level | $37.92 | $23.03 |
| Average True Range (ATR) | 0.19 | 0.64 |
| MACD | -0.24 | -0.06 |
| Stochastic Oscillator | 78.69 | 24.70 |
Price Performance
Historical ComparisonAbout RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.